KPI data tables

MetLife operating metrics behind the KPI charts, newest period first (up to 24 periods per chart). Periods use each company's own fiscal labels where the source does; each table names its source.

MetLife Adjusted Return on Equity (Quarterly) (percent)
PeriodAdjusted ROE
Q3 202619.2
Q2 202617
Q1 202617
Q4 202517.6
Q3 202516.9
Q2 202514.6
Q1 202514.4
Q4 202415.4
Q3 202414.6
Q2 202417.3
Q1 202413.8
Q4 202313.8
Q3 202314.9
Q2 202314.6
Q1 202311.3
Q4 202212.1
Q3 202210.6
Q2 202216.4
Q1 202215.7
Q4 202115.3
Q3 202117
Q2 202117.5
Q1 202116.5
Q4 202015.2

Source: MetLife Form 8-K Exhibit 99.2 Quarterly Financial Supplement, Corporate Overview adjusted ROE (QTD annualized), five period-end columns oldest to newest. Later filing wins, including the Q1 2023 LDTI restatement of 2022. Earliest window filed 2020-02-05 (https://www.sec.gov/Archives/edgar/data/1099219/000109921920000050/ex992qfsq419doc.htm). Latest window filed 2026-11-04 (https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex992qfs8kdoc.htm).

MetLife Asia General Account Assets Under Management at Amortized Cost (Quarterly) (usd_millions)
PeriodAsia GA AUM (amortized cost)
Q3 2026144,969
Q2 2026141,211
Q1 2026140,660
Q4 2025140,168
Q3 2025140,892
Q2 2025139,158
Q1 2025134,352
Q4 2024129,959
Q3 2024135,107
Q2 2024126,997
Q1 2024128,618
Q4 2023130,093
Q3 2023124,684
Q2 2023125,266
Q1 2023127,120
Q4 2022126,335
Q3 2022119,302
Q2 2022122,257
Q1 2022129,935
Q4 2021130,310
Q3 2021130,777
Q2 2021129,411
Q1 2021127,695
Q4 2020129,661

Source: MetLife Form 8-K Exhibit 99.2 Quarterly Financial Supplement, Asia GA AUM at amortized cost (usd_millions), five period-end columns oldest to newest. Later filing wins. Earliest window filed 2020-05-06 (https://www.sec.gov/Archives/edgar/data/1099219/000109921920000200/ex992qfsq120doc.htm). Latest window filed 2026-11-04 (https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex992qfs8kdoc.htm).

MetLife Asia Sales on a Constant Currency Basis (Quarterly) (usd_millions)
PeriodJapan LifeJapan Accident & HealthJapan AnnuitiesJapan OtherOther Asia
Q3 20261221042102290
Q2 20261521181862350
Q1 20261641141271365
Q4 2025168571191254
Q3 2025212611781326
Q2 2025155622272232

Source: MetLife Q3 2026 Quarterly Financial Supplement, filed 2026-11-04, Asia Sales on a Constant Currency Basis table (Exhibit 99.2): https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex992qfs8kdoc.htm. Q2 2025 row from the Q2 2026 supplement (https://www.sec.gov/Archives/edgar/data/1099219/000109921926000048/ex992qfs8kdoc.htm). Sales definition: same supplement, Non-GAAP and Other Financial Disclosures. Q3 2026 Exhibit 99.1 (sales $728 million, down 6 percent constant currency): https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex991earningsreleasetables.htm.

MetLife Group Benefits Life and Non-Medical Health PFOs (Quarterly) (usd_millions)
PeriodGroup LifeGroup Non-Medical Health
Q3 20262,3612,982
Q2 20262,3672,957
Q1 20262,3793,019
Q4 20252,3212,866
Q3 20252,3282,814
Q2 20252,3712,876
Q1 20252,3522,850

Source: MetLife Quarterly Financial Supplement, Group Benefits Other Information table. Q3 2026 Exhibit 99.2, filed 2026-11-04: https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex992qfs8kdoc.htm. Q2 2026 Exhibit 99.2: https://www.sec.gov/Archives/edgar/data/1099219/000109921926000048/ex992qfs8kdoc.htm. Q1 2026 Exhibit 99.2 (Q1 2025 print): https://www.sec.gov/Archives/edgar/data/1099219/000109921926000032/ex992qfsq126.htm. Segment PFO total in Q3 2026 Exhibit 99.1: https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex991earningsreleasetables.htm.

MetLife Adjusted Premiums, Fees and Other Revenues by Segment (usd_millions)
PeriodGroup BenefitsRetirement and Income SolutionsAsiaLatin AmericaEMEAMetLife Investment ManagementCorporate & Other
FY 202525,46912,2626,7686,6062,9019322,470
FY 202424,8708,5946,7575,9362,5487182,956
FY 202323,9298,8326,9695,7272,3467193,444

Source: MetLife Form 10-K for the year ended 31 December 2025, MD&A adjusted premiums, fees and other revenues by segment (FY 2025 $25,469 / $12,262 / $6,768 / $6,606 / $2,901 / $932 / $2,470 million = $57,408 million consolidated; FY 2024 and FY 2023 on the same table). https://www.sec.gov/Archives/edgar/data/1099219/000109921926000013/met-20251231.htm

MetLife Total Assets Under Management (Quarterly) (usd_billions)
PeriodTotal AUM
Q3 2026723.441
Q2 2026748.126
Q1 2026736.291
Q4 2025741.674
Q3 2025632.594
Q2 2025624.287
Q1 2025603.164
Q4 2024585.729

Source: MetLife Form 8-K Exhibit 99.2 Quarterly Financial Supplement, Total AUM row in millions converted to usd_billions, five period-end columns oldest to newest. Later filing wins. Q4 2025: https://www.sec.gov/Archives/edgar/data/1099219/000109921926000008/ex992qfsq425.htm. Q1 2026: https://www.sec.gov/Archives/edgar/data/1099219/000109921926000032/ex992qfsq126.htm. Q2 2026: https://www.sec.gov/Archives/edgar/data/1099219/000109921926000048/ex992qfs8kdoc.htm. Q3 2026 (filed 2026-11-04): https://www.sec.gov/Archives/edgar/data/1099219/000109921926000058/ex992qfs8kdoc.htm.

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites
MetLife (MET) - KPIs | Sterling